Understanding the emerging imaging challenge with GLP-1 medications GLP-1 receptor agonists, including popular drugs like Ozempic, Wegovy, and Mounjaro, have transformed weight loss and diabetes management. Yet as usage surged—reported to have risen about 700% in the United States from 2019 to 2023—so have reports of unusual side effects. A less obvious consequence is their…